Alain Corbier

463 total citations
18 papers, 318 citations indexed

About

Alain Corbier is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Alain Corbier has authored 18 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Alain Corbier's work include Receptor Mechanisms and Signaling (4 papers), Renin-Angiotensin System Studies (4 papers) and Synthesis and Biological Evaluation (4 papers). Alain Corbier is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Renin-Angiotensin System Studies (4 papers) and Synthesis and Biological Evaluation (4 papers). Alain Corbier collaborates with scholars based in France, United States and Italy. Alain Corbier's co-authors include Évelyne Benoit, Jean‐Marc Dubois, Bertrand Heckmann, Pierre Deprez, F. Contard, Farahnaz Farhadian, A Barrieux, L. Rappaport, Jane‐Lise Samuel and R. H. A. Becker and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Journal of Medicinal Chemistry.

In The Last Decade

Alain Corbier

17 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Corbier France 8 168 123 79 52 30 18 318
Véronique Bruban France 13 229 1.4× 59 0.5× 102 1.3× 61 1.2× 41 1.4× 17 430
Yoshiyuki Sugimoto Japan 11 184 1.1× 34 0.3× 71 0.9× 41 0.8× 83 2.8× 20 387
James B. Louttit United Kingdom 5 229 1.4× 140 1.1× 151 1.9× 18 0.3× 51 1.7× 11 494
Jinliang Sui United States 6 490 2.9× 170 1.4× 247 3.1× 11 0.2× 17 0.6× 8 583
Daun Putnam United States 10 281 1.7× 26 0.2× 31 0.4× 23 0.4× 43 1.4× 11 391
Achim Raap Germany 10 198 1.2× 95 0.8× 52 0.7× 17 0.3× 88 2.9× 16 313
Jesusa Capera Spain 11 372 2.2× 113 0.9× 81 1.0× 8 0.2× 23 0.8× 20 468
Clara Serrano‐Novillo Spain 7 285 1.7× 86 0.7× 73 0.9× 8 0.2× 16 0.5× 10 358
Núria Villalonga Spain 11 534 3.2× 257 2.1× 158 2.0× 18 0.3× 22 0.7× 13 672
Chunxia Cronin United States 11 159 0.9× 45 0.4× 38 0.5× 143 2.8× 28 0.9× 17 523

Countries citing papers authored by Alain Corbier

Since Specialization
Citations

This map shows the geographic impact of Alain Corbier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Corbier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Corbier more than expected).

Fields of papers citing papers by Alain Corbier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Corbier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Corbier. The network helps show where Alain Corbier may publish in the future.

Co-authorship network of co-authors of Alain Corbier

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Corbier. A scholar is included among the top collaborators of Alain Corbier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Corbier. Alain Corbier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Poirier, Bruno, Olivier Pasquier, Alain Corbier, et al.. (2024). R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases. British Journal of Pharmacology. 181(13). 1993–2011. 6 indexed citations
2.
Poirier, Bruno, Anne‐Marie Lefebvre, Alain Roccon, et al.. (2022). A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome. PLoS ONE. 17(1). e0257929–e0257929. 6 indexed citations
3.
Briand, Pascale, et al.. (2021). Apelin improves cardiac function mainly through peripheral vasodilation in a mouse model of dilated cardiomyopathy. Peptides. 142. 170568–170568. 6 indexed citations
4.
Beauverger, Philippe, Marie‐Laure Ozoux, Alain Corbier, et al.. (2019). Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Cardiovascular Research. 116(2). 329–338. 36 indexed citations
5.
Briand, Pascale, Alain Corbier, Bruno Poirier, et al.. (2019). 3071Peptidomimetic targeting of CavBeta2 improves contractility in models of senescence- or genetically (MYBPC3 KI)-induced heart failure. European Heart Journal. 40(Supplement_1). 1 indexed citations
6.
Corbier, Alain, et al.. (2011). Oversulfated Chondroitin Sulfate and OSCS-Contaminated Heparin Cause Dose- and Route-Dependent Hemodynamic Effects in the Rat. Toxicological Sciences. 121(2). 417–427. 14 indexed citations
7.
8.
Farhadian, Farahnaz, F. Contard, Alain Corbier, et al.. (1995). Fibronectin expression during physiological and pathological cardiac growth. Journal of Molecular and Cellular Cardiology. 27(4). 981–990. 56 indexed citations
9.
10.
Deprez, Pierre, et al.. (1995). Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas. Bioorganic & Medicinal Chemistry Letters. 5(22). 2611–2616. 7 indexed citations
11.
12.
Deprez, Pierre, et al.. (1995). Balanced AT1 and AT2 angiotensin II antagonists. III. potent and orally active 5-β-ketosulfoxide imidazolyl biphenyl sulfonylureas. Bioorganic & Medicinal Chemistry Letters. 5(22). 2617–2622. 5 indexed citations
13.
Deprez, Pierre, et al.. (1995). Balanced AT1 and AT2 angiotensin II antagonists. I. New orally active 5-carboxyl imidazolyl biphenyl sulfonylureas. Bioorganic & Medicinal Chemistry Letters. 5(22). 2605–2610. 14 indexed citations
14.
Corbier, Alain, et al.. (1994). Effects of 4 Weeks of Treatment with Trandolapril on Renal Hypertension and Cardiac and Vascular Hypertrophy in the Rat. Journal of Cardiovascular Pharmacology. 23. S26–29. 8 indexed citations
15.
Corbier, Alain, et al.. (1994). Effects of 4 Weeks of Treatment with Trandolapril on Renal Hypertension and Cardiac and Vascular Hypertrophy in the Rat. Journal of Cardiovascular Pharmacology. 23. S26–29. 2 indexed citations
16.
Corbier, Alain, et al.. (1994). Effects of 4 weeks of treatment with trandolapril on renal hypertension and cardiac and vascular hypertrophy in the rat.. PubMed. 23 Suppl 4. S26–9. 9 indexed citations
17.
Corbier, Alain, et al.. (1990). Evidence for a direct noncholinergic effect of an organophosphorous compound on guinea-pig papillary muscles: are ventricular arrhythmias related to a Na+/K+ ATPase inhibition?. PubMed. 300. 218–30. 2 indexed citations
18.
Benoit, Évelyne, Alain Corbier, & Jean‐Marc Dubois. (1985). Evidence for two transient sodium currents in the frog node of Ranvier.. The Journal of Physiology. 361(1). 339–360. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Bruban Breakdown of academic impact, for papers by Yoshiyuki Sugimoto Breakdown of academic impact, for papers by James B. Louttit Breakdown of academic impact, for papers by Jinliang Sui Breakdown of academic impact, for papers by Daun Putnam Breakdown of academic impact, for papers by Achim Raap Breakdown of academic impact, for papers by Jesusa Capera Breakdown of academic impact, for papers by Clara Serrano‐Novillo Breakdown of academic impact, for papers by Núria Villalonga Breakdown of academic impact, for papers by Chunxia Cronin
Rankless by CCL
2026